Jens Köhler

6PUBLICATIONS
24CO-AUTHORS
Molecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 29, 2022
Comparative Analysis and Isoform-Specific Therapeutic Vulnerabilities of KRAS Mutations in Non-Small Cell Lung Cancer.

Biagio Ricciuti, Jieun Son, Jeffrey J Okoro

|Nov 18, 2021
Combination of Type I and Type II MET Tyrosine Kinase Inhibitors as Therapeutic Approach to Prevent Resistance.

Magda Bahcall, Cloud P Paweletz, Yanan Kuang

|Aug 02, 2021
Amivantamab: Treating EGFR Exon 20-Mutant Cancers With Bispecific Antibody-Mediated Receptor Degradation.

Jens Köhler, Pasi A Jänne

|Apr 03, 2021
If Virchow and Ehrlich Had Dreamt Together: What the Future Holds for KRAS-Mutant Lung Cancer.

Jens Köhler, Pasi A Jänne

|Feb 04, 2021
ERK Inhibitor LY3214996-Based Treatment Strategies for RAS-Driven Lung Cancer.

Jens Köhler, Yutong Zhao, Jiaqi Li

Pageof 1